Immunologically Nonspecific Mechanisms of Tissue Destruction in the Rejection of Skin Grafts

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1994 May 1

PMID 8163942

Authors

D P Doody

K S Stenger

H J Winn

Affiliations

Soon will be listed here.

Abstract

When mice are lethally irradiated and reconstituted with allogeneic bone marrow cells, their skin is repopulated over a period of several months with Langerhans cells (LC) of marrow donor origin. Skin from such mice, when transplanted to unirradiated syngeneic recipients, became in many cases the sites of intense inflammatory responses that led to varying degrees of destruction of the transplanted skin and in some instances, to rejection of the entire graft. The frequency and intensity of these responses were influenced by the nature of the immunogenetic disparity between the donors and recipients of the marrow cells. Chimeric skin placed on hybrid mice derived from crosses between the marrow donors and recipients behaved in all respects as syngeneic grafts or autografts. When the recipients of the chimeric skin were presensitized to the antigens of the marrow donor, the responses were especially intense, and resulted in all cases in complete rejection. Thus the immunologically mediated attack on the allogeneic LCs was accompanied by widespread and nonspecific destruction of bystander cells. In all cases, the inflammation and tissue damage were confined sharply to the grafted skin, showing clearly that nonspecific or indirect tissue destruction is entirely consistent with highly selective destruction of grafted tissues. This finding removes a major objection to postulated mechanisms of rejection that involve indirect destruction of grafted tissues.

References

Mintz B, Silvers W . Histocompatibility antigens on melanoblasts and hair follicle cells. Cell-localized homograft rejection in allophenic skin grafts. Transplantation. 1970; 9(5):497-505. DOI: 10.1097/00007890-197005000-00009. View

Snell G . The homograft reaction. Annu Rev Microbiol. 1957; 11:439-58. DOI: 10.1146/annurev.mi.11.100157.002255. View

Dvorak H, Mihm Jr M, Dvorak A, Johnson R, Manseau E, Morgan E . Morphology of delayed type hypersensitivity reactions in man. I. Quantitative description of the inflammatory response. Lab Invest. 1974; 31(2):111-30. View

Dvorak H, Mihm Jr M, Dvorak A, BARNES B, Manseau E, Galli S . Rejection of first-set skin allografts in man. the microvasculature is the critical target of the immune response. J Exp Med. 1979; 150(2):322-37. PMC: 2185628. DOI: 10.1084/jem.150.2.322. View

Steinmuller D . Passenger leukocytes and the immunogenicity of skin allografts. J Invest Dermatol. 1980; 75(1):107-15. DOI: 10.1111/1523-1747.ep12521331. View

Jooste S, Colvin R, Soper W, Winn H . The vascular bed as the primary target in the destruction of skin grafts by antiserum. I. Resistance of freshly placed xenografts of skin to antiserum. J Exp Med. 1981; 154(5):1319-31. PMC: 2186525. DOI: 10.1084/jem.154.5.1319. View

Jooste S, Colvin R, Winn H . The vascular bed as the primary target in the destruction of skin grafts by antiserum. II. Loss of sensitivity to antiserum in long-term xenografts of skin. J Exp Med. 1981; 154(5):1332-41. PMC: 2186507. DOI: 10.1084/jem.154.5.1332. View

Woodward J, Shigekawa B, Frelinger J . Bone marrow-derived cells are responsible for stimulation I region-incompatible skin graft rejection. Transplantation. 1982; 33(3):254-9. DOI: 10.1097/00007890-198203000-00009. View

Burdick J . Strong cellular immune responses induced in vivo against minor antigens in the mouse. Immunology. 1986; 58(4):615-20. PMC: 1453106. View

10.

Smith D, Stuart F, Wemhoff G, Quintans J, Fitch F . Cellular pathways for rejection of class-I-MHC--disparate skin and tumor allografts. Transplantation. 1988; 45(1):168-75. DOI: 10.1097/00007890-198801000-00036. View

11.

Rosenberg A, Singer A . Evidence that the effector mechanism of skin allograft rejection is antigen-specific. Proc Natl Acad Sci U S A. 1988; 85(20):7739-42. PMC: 282268. DOI: 10.1073/pnas.85.20.7739. View

12.

Mayer T, Bhan A, Winn H . Immunohistochemical analyses of skin graft rejection in mice. Kinetics of lymphocyte infiltration in grafts of limited immunogenetic disparity. Transplantation. 1988; 46(6):890-9. DOI: 10.1097/00007890-198812000-00020. View

13.

Kievits F, Ivanyi P . A subpopulation of mouse cytotoxic T lymphocytes recognizes allogeneic H-2 class I antigens in the context of other H-2 class I molecules. J Exp Med. 1991; 174(1):15-9. PMC: 2118870. DOI: 10.1084/jem.174.1.15. View

14.

Benichou G, Takizawa P, Olson C, McMillan M, Sercarz E . Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med. 1992; 175(1):305-8. PMC: 2119070. DOI: 10.1084/jem.175.1.305. View

15.

Klein E, Klein G . Detection of an allelic difference at a single gene locus in a small fraction of a large tumour-cell population. Nature. 1956; 178(4547):1389-91. DOI: 10.1038/1781389a0. View

16.

Baldamus C, McKenzie I, Winn H, Russell P . Acute destruction by humoral antibody of rat skin grafted to mice. J Immunol. 1973; 110(6):1532-41. View